PL3884929T3
Ocular implant containing a tyrosine kinase inhibitor
Abstract
This record has no abstract on file.
Term
14.5 yearsto projected expiry
Projected expiry 24 March 2041, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
63 members in 21 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 202062994391 | United States of America | P | |
| 2020029827 | United States of America | W | |
| 202063106276 | United States of America | P | |
| 202163148463 | United States of America | P |
Members63
| Document | Office | Kind | |
|---|---|---|---|
| US2020337989A1 | United States of America | A1 | |
| WO2020219890A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP3884929A1 | European Patent Office (EPO) | A1 | |
| CA3171563A1 | Canada | A1 | |
| CA3234679A1 | Canada | A1 | |
| WO2021195163A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2021308043A1 | United States of America | A1 | |
| CN113939271A | China | A | |
| TW202202138A | Taiwan Province of China | A | |
| US2022079876A1 | United States of America | A1 | |
| US11439592B2 | United States of America | B2 | |
| AU2021244485A1 | Australia | A1 | |
| IL296687A | Israel | A | |
| US2022347094A1 | United States of America | A1 | |
| BR112022018815A2 | Brazil | A2 | |
| KR20220157462A | Republic of Korea | A | |
| MX2022010333A | Mexico | A | |
| CN115461040A | China | A | |
| US11534396B2 | United States of America | B2 | |
| US2023040637A1 | United States of America | A1 | |
| CL2022002606A1 | Chile | A1 | |
| US2023118774A1 | United States of America | A1 | |
| JP2023518820A | Japan | A | |
| EP3884929B1 | European Patent Office (EPO) | B1 | |
| FI3884929T3 | Finland | T3 | |
| PT3884929T | Portugal | T | |
| DK3884929T3 | Denmark | T3 | |
| EP4252725A2 | European Patent Office (EPO) | A2 | |
| PL3884929T3This record | Poland | T3 | |
| HRP20230800T1 | Croatia | T1 | |
| ES2952677T3 | Spain | T3 | |
| JP7378638B2 | Japan | B2 | |
| EP4252725A3 | European Patent Office (EPO) | A3 | |
| HUE062928T2 | Hungary | T2 | |
| JP2024012435A | Japan | A | |
| AU2021244485B2 | Australia | B2 | |
| AU2024203448A1 | Australia | A1 | |
| US2024285518A1 | United States of America | A1 | |
| KR102707942B1 | Republic of Korea | B1 | |
| KR20240142585A | Republic of Korea | A | |
| ZA202209352B | South Africa | B | |
| MX2024012181A | Mexico | A | |
| MX2024012181A | Mexico | A | |
| CN115461040B | China | B | |
| CN113939271B | China | B | |
| JP7668858B2 | Japan | B2 | |
| JP7668858B6 | Japan | B6 | |
| CN120227316A | China | A | |
| US12357565B2 | United States of America | B2 | |
| CN120346152A | China | A | |
| AU2024203448B2 | Australia | B2 | |
| US2025332094A1 | United States of America | A1 | |
| EP4252725B1 | European Patent Office (EPO) | B1 | |
| IL296687B1 | Israel | B1 | |
| IL324227A | Israel | A | |
| PT4252725T | Portugal | T | |
| FI4252725T3 | Finland | T3 | |
| DK4252725T3 | Denmark | T3 | |
| US20260053735A1 | United States of America | A1 | |
| ES3057263T3 | Spain | T3 | |
| PL4252725T3 | Poland | T3 | |
| EP4706652A2 | European Patent Office (EPO) | A2 | |
| HRP20260021T1 | Croatia | T1 |
Numbers
- Publication
- 3884929
- Application
- 21164737
Titles2
- English
- OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
- Polish
- WPROWADZANY DO OKA WSZCZEP ZAWIERAJĄCY INHIBITOR KINAZY TYROZYNOWEJ
Classification
- CPC, 10
- A61K9/0019
- A61K9/0051
- A61K9/06
- A61K31/4439
- A61P27/02
- A61K47/10
- A61F9/0017
- A61K31/4427
- A61K47/34
- A61K45/06
- IPC, 4
- A61F9 00
- A61K9 00
- A61K31 4439
- A61K47 10